Abstract

e19033Background: Prognostication in post-transplant lymphoproliferative disorders (PTLD) is limited to clinical factors, with no validated tissue biomarkers. It is suggested that the degree of CD3...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Posttransplant Lymphoproliferative Disorder Following Kidney Transplant
Alicia K Morgans ... Donald E Tsai
American journal of kidney diseases : the official journal of the National Kidney Foundation | VOL. 55
Alicia K Morgans, et. al.Alicia K Morgans ... Donald E Tsai
05 Dec 2009
Travel Medicine and Transplant Tourism in Solid Organ Transplantation
C.N Kotton ... P.L Hibberd
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | VOL. 13
C.N Kotton, et. al.C.N Kotton ... P.L Hibberd
01 Mar 2013
A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.
Erick F Mayer ...
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons | VOL. 20
Erick F Mayer, et. al.Erick F Mayer ...
10 Mar 2020
II. Challenges in the management of post-transplant lymphoproliferative disorder.
Luca Nassi ... Gianluca Gaidano
Hematological oncology | VOL. Suppl 33 1
Luca Nassi, et. al.Luca Nassi ... Gianluca Gaidano
01 Jun 2015
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Erratum: Neoadjuvant Chemotherapy in High-Grade Myxoid Liposarcoma: Results of the Expanded Cohort of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish Sarcoma Groups (PSG).
-
Journal of Clinical Oncology | VOL. -
--
03 Jul 2024
Denosumab Prevents Bone Loss and Microarchitectural Deterioration in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression Therapy: A Randomized Controlled Trial.
Sabashini K Ramchand ... Mathis Grossmann
Journal of Clinical Oncology | VOL. -
Sabashini K Ramchand, et. al.Sabashini K Ramchand ... Mathis Grossmann
02 Jul 2024
Final Results From a Phase I Trial and Expansion Cohorts of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced/Metastatic Genitourinary Tumors.
Andrea B Apolo ... Amir Mortazavi
Journal of Clinical Oncology | VOL. -
Andrea B Apolo, et. al.Andrea B Apolo ... Amir Mortazavi
02 Jul 2024
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Paul A Meyers ... Joseph A Ludwig
Journal of Clinical Oncology | VOL. -
Paul A Meyers, et. al.Paul A Meyers ... Joseph A Ludwig
02 Jul 2024
View more papers